Hematology is a part of drug, which manages the study of blood, blood illnesses and blood-forming organs. Hematology incorporates issues related with white platelets, red platelets, bone marrow, lymph, and platelets. It additionally influences the fluid part of blood known as plasma. Hematology incorporates different IVD advancements, such as blood analysis, stream cytometry, molecular and atomic diagnostics, hemostasis, histology, and cytology. Some of the blood-related infections are weakness, leukemia, myelofibrosis, threatening lymphomas, blood transfusion and bone marrow. Hematology also analyze the weakness, disease, hemophilia, and blood coagulating. The report provides analysis of global hematology diagnostics market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. The global Hematology Diagnostics market is anticipated to grow at considerable CAGR above 5.8% over the forecast period and reach US$ 9.54 Bn by 2026.
|Market||Hematology Diagnostics Market|
|Analysis Period||2016 - 2026|
|Forecast Data||2019 - 2026|
|Segments Covered||By Product, By Test Type, By End Use and By Geography|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories, EKF Diagnostics, and Beckman Coulter, Inc.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
|Customization Scope||10 hrs of free customization and expert consultation|
Rise in frequency of blood disorders, introduction of technologically enhanced automated hematology analyzers, technological advancements and growing awareness among people are some of the fundamental factors which are responsible for the growth of the hematology diagnostics market globally. Huge demand for lab automation and increment in consolidation among market players and diagnostic labs are key factors that are driving the worldwide hematology diagnostics market during the forecast period. Point-Of-Care (POC) hematology tests are easy to understand as they diminish the requirement for user training alongside enabling remote testing. Besides, these tests decrease the turnaround time. Rising adoption of these tests is foreseen to fuel the market growth over the estimated time frame. Expanding number of diagnostic centers and accessibility of advanced instruments are expected to fuel the demand for haematology diagnostics. However, high cost of the automated instruments and lack of awareness among people in developing economies may hamper the growth of the haematology diagnostics market growth.
Market by Product
Market by Test Type
Market by End Use
Market by Geography
The market research study on “Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026” offers a detailed insights on global hematology diagnosticsmarket entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global hematology diagnosticsmarket by product, test type, end use and major geographic regions. The report also covers basic healthcare development policies.
The company profiling of key players in the global Hematology Diagnostics market includes company overview, major business strategies and revenues. The key players of the market are Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories, EKF Diagnostics, and Beckman Coulter, Inc.